but one of the biggest potential projects going forward is the DOD joint venture to look at electroporation vaccination of all military personnel and contractors. That $3.5 million project looms very big on the horizon. If it works for the US, other countries will follow. Realistically, the possible difference between electroporation and pneumatic syringes (aka, jet injectors) in achieving a high titer antibody response is a biggie. If the "best in class" antibody responses can be met by electroporation, that could be a tremendous breakthrough. Look at how the study will be designed: getting a better response (more antibody) more quickly (sooner). If either or both of these criteria can be demonstrated over jet injectors, the new technology will be phased-in very quickly by DOD. There are a lot of projects out there that suggest Inovio will do well in the next few years. I gave this company 3 years (based on my planning model) to be successful. They are pretty much on target after buying in two months ago.
I totally agree. I noted a while back that INO hiring someone versed in 3D printing / engineering. The following is from the INo website:
Inovio is currently expanding its device research and development efforts and is seeking a well-qualified individual to design and develop products for medical device projects using 2D and 3D software programs.
My comments: To me, it seems that INO is doing something incredibly smart - manufacturing a low cost surface EP device (prior DOD / INO pr referred to a "patch") using 3D printing that could be easily disseminated to people in the field. I think this represent a tremendous revenue source in the not too distant future.